SCHEMBL3220018

SCHEMBL3220018

CCCCCS(=O)(=O)NC(=O)O

nearest known ligand 0.44

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.43
FAAH O00519 2/20 0.41
AKR1B1 P15121 1/20 0.39
CES2 O00748 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9491708 0.93 ALDH1A1 (0.39) PTPN1AKR1B1
Water SCHEMBL3203989 0.91 ALDH1A1 (0.38) PTPN1AKR1B1
SCHEMBL8091952 0.84 FAAH (0.43) PTPN1FAAHCES2
SCHEMBL5154677 0.84 KDM4E (0.35) PTPN1
SCHEMBL13113281 0.83 FAAH (0.41) PTPN1FAAHCES2
Carbamic Acid SCHEMBL10399044 0.82 PTPN1 (0.40) PTPN1FAAH
SCHEMBL1347954 0.81 RELA (0.41) FAAH
SCHEMBL9675528 0.81 FAAH (0.40) PTPN1FAAH
SCHEMBL4668386 0.81 FAAH (0.45) PTPN1FAAHCES2
SCHEMBL4296201 0.81 FAAH (0.45) PTPN1FAAHCES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100041892-A1 Therapeutic agent for diabetes ABE HIDENORI 2010-02-18 US claimed
US-20080009530-A1 Therapeutic Agent for Diabetes TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-10 US claimed
EP-0968193-B1 PHENYLSULPHONYL UREAS, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES AND PLANT-GROWTH REGULATORS BAYER CROPSCIENCE GMBH (DE) 2007-02-21 EP claimed
EP-0900023-B1 SUBSTITUTED AMINOMETHYL PHENYL SULPHONYL UREAS, THEIR PRODUCTION AND THEIR USE AS HERBICIDES AND PLANT GROWTH REGULATORS BAYER CROPSCIENCE GMBH (DE) 2002-11-27 EP claimed
EP-0575503-B1 HERBICIDAL PYRIDINE SULFONAMIDE DU PONT (US) 1999-11-24 EP claimed
US-5925596-A PRE-EMERGENCE AND POST-EMERGENCE HERBICIDES HOECHST-SCHERING AGREVO GMBH (DE) 1999-07-20 US claimed
EP-0502740-B1 Herbicidal pyridine sulfonamide DU PONT (US) 1998-05-27 EP claimed
US-5380910-A Dehalogeno coupling IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 1995-01-10 US claimed
EP-0575503-A1 HERBICIDAL PYRIDINE SULFONAMIDE E.I. DU PONT DE NEMOURS AND COMPANY (US) 1993-12-29 EP claimed
WO-1992015576-A1 HERBICIDAL PYRIDINE SULFONAMIDE E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-09-17 WO claimed
EP-0502740-A1 Herbicidal pyridine sulfonamide E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-09-09 EP claimed
EP-0169815-B1 N-ARYLSULFONYL-N'-TRIAZINYL- AND -PYRIMIDINYL UREAS CIBA-GEIGY AG (CH) 1988-11-02 EP claimed
EP-0139612-B1 HERBICIDAL AGENT CIBA-GEIGY AG (CH) 1988-02-10 EP claimed
EP-0084020-B1 N-ARYLSULFONYL-N'-PYRIMIDINYL UREAS CIBA-GEIGY AG (CH) 1987-09-16 EP claimed
JP-6298723-A None JP disclosed
US-20100041892-A1 Therapeutic agent for diabetes ABE HIDENORI 2010-02-18 US disclosed
US-20090270631-A1 Therapeutic agent for diabetes ABE HIDENORI 2009-10-29 US disclosed
EP-0007567-A1 Aqueous hydraulic liquid and concentrates thereof having improved corrosion-protective properties for metals Theunissen, Helmut (DE) 1980-02-06 EP disclosed
US-3933894-A HERBICIDES MONSANTO COMPANY (US) 1976-01-20 US disclosed
US-3933894-A HERBICIDES MONSANTO COMPANY (US) 1976-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270631-A1 Therapeutic agent for diabetes FABP4, SLC5A1, SLC5A2 PTPN1 596/4885FAAH 1354/4885AKR1B1 121/4885
US-20080009530-A1 Therapeutic Agent for Diabetes FABP4, SLC5A1, SLC5A2 PTPN1 583/4885FAAH 955/4885AKR1B1 59/4885
US-20100041892-A1 Therapeutic agent for diabetes FABP4, SLC5A1, SLC5A2 PTPN1 596/4885FAAH 1354/4885AKR1B1 121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.